Killer cocktail fights brain cancer

The tumor (dark region, left) in this mouse brain was eradicated (arrowhead, right) with a novel drug cocktail, according to a Journal of Experimental Medicine study. Credit: vom Berg et al., 2013

A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine.

Glioblastoma is the most aggressive form of , and current treatments only modestly prolong patient survival. Immune cells called T cells have the capacity to attack and kill , but tumors can counteract this attack by creating an environment that dampens T cell activity. T cells have ways of limiting their own activation (and thus autoimmunity), one of which is to express inhibitory cell surface proteins upon activation. In other cancer models, strategies to block these inhibitory proteins have been shown to reinvigorate T cell activation and thus promote .

Burkhard Becher and colleagues at the University of Zurich now show that a two-pronged approach is most effective against glioblastoma. They simultaneously injected mice with a T cell–boosting protein called interleukin-12 and a drug that blocks the inhibitory receptor CTLA-4. The cocktail eradicated the animals' brain tumors.

Whether these findings will pave the way for a new therapeutic approach to treat glioblastoma in humans awaits clinical trials.

More information: vom Berg, J., et al. 2013. J. Exp. Med. DOI: 10.1084/jem.20130678

add to favorites email to friend print save as pdf

Related Stories

New immuno-therapy for malignant brain tumors

Nov 25, 2013

Animal experiments show that it is relatively easy to treat cancer in the early stages. However, it is far more difficult to successfully treat advanced cancer. Treatment of brain tumors is particularly challenging because ...

Recommended for you

Generation of tanners see spike in deadly melanoma

7 hours ago

(AP)—Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.

Penn team makes cancer glow to improve surgical outcomes

7 hours ago

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

Cancer: Tumors absorb sugar for mobility

20 hours ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

User comments